Short-term dietary modifications—particularly pseudoallergen and histamine restrictions—improve symptom scores and quality of life in chronic idiopathic urticaria, offering a viable adjunctive management strategy.
Chronic idiopathic urticaria (CIU), also widely categorized as chronic spontaneous urticaria (CSU), presents persistent wheals, angioedema, or both lasting for more than 6 weeks without a readily identifiable external trigger. The condition stems from spontaneous cutaneous mast cell activation and subsequent release of inflammatory mediator. Because standard pharmacological interventions face therapeutic limitations and underlying pathways remain complex, investigators monitored the extent to which nutritional modifications can modify disease progression and clinical outcomes.
Scoping review design and methodology
Researchers executed a scoping review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards, querying databases including EMBASE, Ovid MEDLINE, and Web of Science for literature published between 2015 and 2025. Search strings incorporated variations of chronic idiopathic or spontaneous urticaria paired with terms focused on diet, nutritional influence, and dietary regimens.
From an initial yield of 121 records, 9 fulfilled initial eligibility thresholds, and 8 studies successfully passed critical appraisal. The included investigations evaluated diverse nutritional strategies—spanning the Mediterranean diet, low-pseudoallergen protocols, pseudoallergen-free diets, and low-histamine regimens—with intervention lengths ranging from seven to just over 39 days. Validated metrics such as the Urticaria Control Test (UCT), Urticaria Activity Score (UAS), and Chronic Urticaria Quality of Life (CU-Q2oL) questionnaire tracked clinical responses.
Key dietary outcomes and nutritional associations
The 8 reviewed studies demonstrated consistent short-term clinical improvements across varied geographical and dietary contexts:
Methodological limitations and research gaps
Despite encouraging patient-reported benefits, the current body of literature carries notable constraints. The authors emphasized that existing trials suffered from small sample sizes, short intervention windows, and restricted immunological depth. Furthermore, confounding variables at the participant level remain under-controlled.
Clinical implications
Hence, personalized nutritional adjustments—particularly those limiting histamine and pseudoallergens serve as a valuable adjunctive management strategy for CIU sufferers.
Cureus
The Role of Diet in the Management of Chronic Idiopathic Urticaria: A Scoping Review
Olivia D'Alessio et al.
Comments (0)